BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34146173)

  • 21. Do the circulating Pre-S/S quasispecies influence hepatitis B virus surface antigen levels in the HBeAg negative phase of HBV infection?
    Cavallone D; Ricco G; Oliveri F; Colombatto P; Moriconi F; Coco B; Romagnoli V; Salvati A; Surace L; Bonino F; Brunetto MR
    Aliment Pharmacol Ther; 2020 Jun; 51(12):1406-1416. PubMed ID: 32390175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic variations of hepatitis B virus strains in patients chronically coinfected with hepatitis B and human immunodeficiency viruses.
    Santos EA; Niel C; Vianna CO; De Sá CA; Gomes SA
    Acta Virol; 1998 Feb; 42(1):27-33. PubMed ID: 9645240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of genotypes C and D of the hepatitis B virus in Japan: a clinical and molecular biological study.
    Duong TN; Horiike N; Michitaka K; Yan C; Mizokami M; Tanaka Y; Jyoko K; Yamamoto K; Miyaoka H; Yamashita Y; Ohno N; Onji M
    J Med Virol; 2004 Apr; 72(4):551-7. PubMed ID: 14981757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complete genome analysis of hepatitis B virus in Qinghai-Tibet plateau: the geographical distribution, genetic diversity, and co-existence of HBsAg and anti-HBs antibodies.
    Liu H; Shen L; Zhang S; Wang F; Zhang G; Yin Z; Qiu F; Liang X; Wang F; Bi S
    Virol J; 2020 Jun; 17(1):75. PubMed ID: 32532295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela.
    Gutiérrez C; Devesa M; Loureiro CL; León G; Liprandi F; Pujol FH
    J Med Virol; 2004 Jun; 73(2):200-7. PubMed ID: 15122793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Determination of hepatitis B virus genotypes by DNA sequence analysis in patients from Ankara, Turkey].
    Külah C; Cirak MY
    Mikrobiyol Bul; 2010 Apr; 44(2):245-53. PubMed ID: 20549959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon.
    Gachara G; Magoro T; Mavhandu L; Lum E; Kimbi HK; Ndip RN; Bessong PO
    AIDS Res Ther; 2017 Mar; 14(1):11. PubMed ID: 28270215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus genotype D predominates HBsAg-positive egyptian blood donors and is mainly associated with a negative HBeAg serostatus.
    Habil FE; Mahdi WK; Abdelwahab SF; Abdel-Hamid M
    Intervirology; 2013; 56(5):278-83. PubMed ID: 23887183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular analysis of the hepatitis B virus presurface and surface gene in patients from eastern China with occult hepatitis B.
    Huang X; Qin Y; Li W; Shi Q; Xue Y; Li J; Liu C; Hollinger FB; Shen Q
    J Med Virol; 2013 Jun; 85(6):979-86. PubMed ID: 23588723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular epidemiology and genetic diversity of hepatitis B virus in Ethiopia.
    Hundie GB; Raj VS; Michael DG; Pas SD; Osterhaus AD; Koopmans MP; Smits SL; Haagmans BL
    J Med Virol; 2016 Jun; 88(6):1035-43. PubMed ID: 26629781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular epidemiology of hepatitis B virus in Dakar, Sénégal.
    Vray M; Debonne JM; Sire JM; Tran N; Chevalier B; Plantier JC; Fall F; Vernet G; Simon F; Mb PS
    J Med Virol; 2006 Mar; 78(3):329-34. PubMed ID: 16419106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors.
    Kuhns MC; McNamara AL; Holzmayer V; Cloherty GA
    Virol J; 2019 Apr; 16(1):43. PubMed ID: 30943997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occult hepatitis B virus infection before and 1 year after start of HAART in HIV type 1-positive patients.
    Pogány K; Zaaijer HL; Prins JM; Wit FW; Lange JM; Beld MG
    AIDS Res Hum Retroviruses; 2005 Nov; 21(11):922-6. PubMed ID: 16386107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
    Zhang RF; Liu L; Zheng YF; Shen YZ; Chen J; Gu SM; Wang JR; Lu HZ
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [HBV C gene mutation in the transmission from father to infant].
    Wang SS; Li MM; Peng GF; Li WL; Jin HL; Xiao H; Zeng NH; Wang ZB; Huang JL; Su JX
    Zhonghua Er Ke Za Zhi; 2003 Nov; 41(11):845-8. PubMed ID: 14728893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occult hepatitis B virus infection with positive hepatitis B e antigen.
    Han Z; Liu Y; Pan J; Bi Y; Liu J; Zhou YH
    Clin Chim Acta; 2015 Jan; 438():266-8. PubMed ID: 25218700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen-negative infection and associated viral variants.
    Chowdhury A; Santra A; Chakravorty R; Banerji A; Pal S; Dhali GK; Datta S; Banerji S; Manna B; Chowdhury SR; Bhattacharya SK; Mazumder DG
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1712-20. PubMed ID: 16246191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B virus markers in anti-HBc only positive individuals.
    Weber B; Melchior W; Gehrke R; Doerr HW; Berger A; Rabenau H
    J Med Virol; 2001 Jul; 64(3):312-9. PubMed ID: 11424120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus basal core promoter mutations A1762T/G1764A are associated with genotype C and a low serum HBsAg level in chronically-infected HBeAg-positive Chinese patients.
    Yan CH; Zhao CY; Ding H; Peng YQ; Jin PY; Yan L; Zhuang H; Li T
    Antiviral Res; 2012 Nov; 96(2):108-14. PubMed ID: 22960603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.